Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Plos One
|
September 21, 2018
No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
Alicia Gutierrez-Valencia, Coral García, Pompeyo Viciana, et al.
Diseases of the Colon and Rectum
|
October 25, 2021
Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program
Yusnelkis Milanés Guisado, César Sotomayor, María Fontillón, et al.
The Journal of Vascular Access
|
January 24, 2012
Tunneled hemodialysis catheter-related bloodstream infections: a prospective multicenter cohort study from Spain
Almudena Martín-Peña, Rafael Luque Márquez, M José Marco Guerrero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 28, 2017
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial
Alicia Gutierrez-Valencia, Omar J Benmarzouk-Hidalgo, Inmaculada Rivas-Jeremías, et al.
Microbiology Spectrum
|
June 25, 2024
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, et al.
AIDS and Behavior
|
May 14, 2025
Long-Term Health-Related Quality of Life in People Living with HIV Who Present to Care with AIDS or Severe Immunodeficiency: The CoRIS AIDS Survivors Study
Julia Portilla-Tamarit, María José Fuster-RuizdeApodaca, Irene Portilla-Tamarit, et al.
Antimicrobial Agents and Chemotherapy
|
March 25, 2015
Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy
Alicia Gutierrez-Valencia, Rosa Ruiz-Valderas, Omar J Ben-Marzouk-Hidalgo, et al.
The Journal of Infectious Diseases
|
July 10, 2018
Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients
Luis F López-Cortés, María Trujillo-Rodríguez, Alicia Báez-Palomo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 14, 2019
Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice
Karin Neukam, Marcial Delgado Fernández, José Hernández Quero, et al.
Open Forum Infectious Diseases
|
April 1, 2024
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile
Maria Luisa Montes, Carmen Busca, Nuria Espinosa, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Plos One
|
September 21, 2018
No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
Alicia Gutierrez-Valencia, Coral García, Pompeyo Viciana, et al.
Diseases of the Colon and Rectum
|
October 25, 2021
Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program
Yusnelkis Milanés Guisado, César Sotomayor, María Fontillón, et al.
The Journal of Vascular Access
|
January 24, 2012
Tunneled hemodialysis catheter-related bloodstream infections: a prospective multicenter cohort study from Spain
Almudena Martín-Peña, Rafael Luque Márquez, M José Marco Guerrero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 28, 2017
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial
Alicia Gutierrez-Valencia, Omar J Benmarzouk-Hidalgo, Inmaculada Rivas-Jeremías, et al.
Microbiology Spectrum
|
June 25, 2024
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, et al.
AIDS and Behavior
|
May 14, 2025
Long-Term Health-Related Quality of Life in People Living with HIV Who Present to Care with AIDS or Severe Immunodeficiency: The CoRIS AIDS Survivors Study
Julia Portilla-Tamarit, María José Fuster-RuizdeApodaca, Irene Portilla-Tamarit, et al.
Antimicrobial Agents and Chemotherapy
|
March 25, 2015
Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy
Alicia Gutierrez-Valencia, Rosa Ruiz-Valderas, Omar J Ben-Marzouk-Hidalgo, et al.
The Journal of Infectious Diseases
|
July 10, 2018
Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients
Luis F López-Cortés, María Trujillo-Rodríguez, Alicia Báez-Palomo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 14, 2019
Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice
Karin Neukam, Marcial Delgado Fernández, José Hernández Quero, et al.
Open Forum Infectious Diseases
|
April 1, 2024
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile
Maria Luisa Montes, Carmen Busca, Nuria Espinosa, et al.
Page
of 6